My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Tesla Is In Its AI Era: $3 Trillion Market Ca...
Microsoft, Palantir Lead A Software Rout Not...
Nasdaq Hits Record $5 Billion Revenue As Tech...
Nvidia Secures Approval For $105 Million Taiw...
Salesforce Hits Fresh 52-Week Low As Microsof...
Meta Stock Climbs After Q4 Reveals Blue Skies...
Microsoft Stock Plummets After Q2 Results: An...
Boeing Expands Global Footprint With Air Indi...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) (NYSE: NVS)

    Overview
    current price
    $148.91
    $148.91
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    148.91
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.59 M
    1 day
    0.00 - 0.00
    52 weeks
    97.72 - 152.48
    p/e
    25.15
    beta
    0.5150
    market cap
    314.56 B
    dividend yield
    0.00%
    Industry
    -
    NVS by TradingView
    News and Commentary
    Novartis Builds US Drug Reserves Against Potential Tariffs Novartis AG (NVS 
    Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva Novartis AG (NVS 
    3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs On July 8, US President Donald Trump shook the biopharmaceutical sector by announcing a tariff of up to 200% on pharmaceuticals, which would take effect "very soon." 80% of presc...
    Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
    Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'Th... Alphabet Inc.'s (GOOG&...
    Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Com... Novo Nordisk A/S (NVS&n...
    Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainti... Novartis AG (NVS 
    Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...
    US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could... Monday, the U.S. Department of Health and Human Services (HHS) announced that Medicare enrollees will benefit from reduced prices on 54 drugs through Medicare Part B, effective f...
    Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Dr... Swiss pharma giant Novartis AG (
    StockTwits
    StockTwits
    Most Shared
    Dan Ives Sees 25% Tech Stock Breakout — Micron And Three Bargain Stocks Stand Out
    US Consumer Sentiment Hits 5-Month Highs As Inflation Worries Fall To 1-Year Low
    Nvidia Takes On Robotaxis With Chips, Software And Big Ambitions
    Most Popular
    Sam Altman To Host AI Town Hall — Asks Builders To Submit Questions As OpenAI Begins To Build 'New Generation Of Tools'
    Meta Pauses Global Launch Of Ray-Ban Smart Glasses After US Rush
    Nvidia Is Bank of America's Top Chip Pick: AI Demand, Pricing Power Drive Growth
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    Covid-19
    China
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?